Skip to content

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

Date: August 24, 2026

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to learn more about them. Read their answers, including a top tip for data management, below.

  • Name: Dr. Santosh Karthikeyan Viswanathan
  • Job Title: Data & AI Leader
  • Organisation: Independent
  • Role at ACDM: Board Member and APAC Chair

Provide a brief summary of your education and work experience to date

    • I hold an undergraduate degree in Chemistry and master’s degrees in Business Administration, IT and Psychology. I earned a PhD in Organizational Behaviour and completed a Data Fellowship in the UK. I also hold an honorary doctorate in IT. As a lifelong learner, I have earned over 200 global certifications across various areas covering technology, people and process.
    •  I am recognized as one of the top Data and AI Leaders in India, with a career marked by documented achievements, strong business and technical acumen and experience leading IT and clinical operations, projects and teams globally.
    • My experience spans two sectors: IT organizations such as HCL Technologies, Accenture and Cognizant and biopharmaceutical companies such as Pfizer and AstraZeneca.
    • I am passionate about mentoring young talent to help them build careers in Data and AI.

If you were on a desert island, what three things would you take with you and why?

    • My sunglasses, phone and power bank – to stay cool, connected to the world and keep going.

If you were not in the job you are in, what would you do?

    • I would align myself with Nature and live in a place with no electronic devices.

What’s the best piece of advice you have ever been given?

    • Ask for help when you need it – That was the reply I got when I emailed a retiring colleague early in my career. After spending decades in the corporate world, her advice was simple and it’s stayed with me ever since.

If you could learn one new skill today, what would it be?

    • To get a Private Pilot Licence and fly a private jet.

Santosh’s Top Tip for Clinical Data Managers:

Technology is an enabler — not everything needs to be automated. AI adoption is scaling fast, but the real win is not in automating blindly; it’s in stepping back and asking, ‘How do we optimize our ways of working first and where can AI genuinely add value?’ And yes, governance plays a key role in this journey, keeping in mind the regulated industry we are in.

 


 

Explore More News

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Read More

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Read More

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Read More

Welcome Algorics as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .

Read More

Consultation response on legislative proposals for clinical trials

The MHRA have published the public consultation response to the proposals to reform the . . .

Read More

New MHRA Guidance

The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .

Read More

FDA Guidance for Industry 

The FDA has issued a final guidance to provide information on risk-based approaches to . . .

Read More